What You Need to Know About Bispecific Antibody Immunotherapy

Immunotherapy is one of the newest treatments in the fight against cancer. Bispecific antibody immunotherapy adds a new dimension that may bring even more hope to cancer patients. Join the Cancer Support Community’s Senior Director of Education, Rachel Saks, MSS, LSW, OSW-C, for a talk with Ian Flinn, MD and learn about this innovative new cancer treatment. Dr. Flinn is the Director of Lymphoma Research at the Sarah Cannon Research Institute. Dr. Flinn also serves as the director for the Sarah Cannon Center for Blood Cancer at Tennessee Oncology and TriStar Centennial Medical Center.